🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG)

Recruitingn/aAges 20 Years - 90 YearsAllNational Defense Medical Center, Taiwan
NCT07488052 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective multicenter observational study will validate the accuracy of a previously developed artificial intelligence-enabled single-lead electrocardiogram (AI-ECG) model for identifying low ejection fraction and other structural heart disease phenotypes. Adult participants receiving a model-compatible single-lead electrocardiogram (ECG) (Apple Watch and QOCA ECG102D) and transthoracic echocardiography at five hospitals in Taiwan will be enrolled between March 1, 2026 and June 30, 2026. Model predictions will be compared with echocardiographic reference standards obtained within 30 days after the index ECG.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 20 years or older * Single-lead ECG recorded using a study-compatible device * Ability to comply with study procedures and, when applicable, provide informed consent according to local institutional review board (IRB) requirements * No transthoracic echocardiography performed within 90 days before the index ECG Exclusion Criteria: * ECG signal quality insufficient for prespecified AI analysis * No transthoracic echocardiography available within 30 days after the index ECG * Echocardiography unavailable or technically inadequate for determining left ventricular ejection fraction (EF)
💊

What it tests

  • Single-Lead ECG Acquisition [Apple Watch and QOCA ECG102D]
📍

Where

1 site
Taipei Medical University WanFang Hospital; Far Eastern Memorial Hospital; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Chi Mei Medical Hospital; and China Medical University Hospital
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy